H. M. Kvasnicka

1.4k total citations
56 papers, 995 citations indexed

About

H. M. Kvasnicka is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, H. M. Kvasnicka has authored 56 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 42 papers in Hematology and 14 papers in Rheumatology. Recurrent topics in H. M. Kvasnicka's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (38 papers), Chronic Myeloid Leukemia Treatments (24 papers) and Acute Myeloid Leukemia Research (21 papers). H. M. Kvasnicka is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (38 papers), Chronic Myeloid Leukemia Treatments (24 papers) and Acute Myeloid Leukemia Research (21 papers). H. M. Kvasnicka collaborates with scholars based in Germany, United States and Italy. H. M. Kvasnicka's co-authors include Jürgen Thiele, Volker Diehl, J. Thiele, Jüergen Thiele, R. Zankovich, J. Thiele, R. Fischer, Annette Schmitt‐Graeff, J. Thiele and Markus Jungehülsing and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

H. M. Kvasnicka

53 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. M. Kvasnicka Germany 19 712 622 442 250 104 56 995
Rebecca R. Laborde United States 12 535 0.8× 553 0.9× 384 0.9× 127 0.5× 186 1.8× 18 1.2k
Andrea L. Dewar Australia 10 256 0.4× 426 0.7× 161 0.4× 233 0.9× 294 2.8× 11 796
R Ayats Spain 11 590 0.8× 237 0.4× 180 0.4× 76 0.3× 80 0.8× 23 742
C. Y. Tso Canada 6 1.2k 1.7× 1.4k 2.2× 96 0.2× 664 2.7× 89 0.9× 6 1.6k
Antonella Bardi Italy 21 624 0.9× 460 0.7× 221 0.5× 48 0.2× 240 2.3× 51 1.2k
Simonetta Kerim Italy 15 121 0.2× 232 0.4× 144 0.3× 44 0.2× 137 1.3× 34 521
Claire L. Green United Kingdom 5 296 0.4× 504 0.8× 359 0.8× 126 0.5× 51 0.5× 6 819
Natalia López-Holgado Spain 10 466 0.7× 336 0.5× 235 0.5× 23 0.1× 129 1.2× 19 792
RJ Jacobson United States 11 915 1.3× 1.0k 1.6× 261 0.6× 319 1.3× 65 0.6× 16 1.2k
Mitchell A. Bitter United States 14 231 0.3× 556 0.9× 301 0.7× 132 0.5× 260 2.5× 23 1.1k

Countries citing papers authored by H. M. Kvasnicka

Since Specialization
Citations

This map shows the geographic impact of H. M. Kvasnicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. M. Kvasnicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. M. Kvasnicka more than expected).

Fields of papers citing papers by H. M. Kvasnicka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. M. Kvasnicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. M. Kvasnicka. The network helps show where H. M. Kvasnicka may publish in the future.

Co-authorship network of co-authors of H. M. Kvasnicka

This figure shows the co-authorship network connecting the top 25 collaborators of H. M. Kvasnicka. A scholar is included among the top collaborators of H. M. Kvasnicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. M. Kvasnicka. H. M. Kvasnicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thiele, Jürgen, H. M. Kvasnicka, Umberto Gianelli, et al.. (2025). Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification. Blood Cancer Journal. 15(1). 31–31. 2 indexed citations
3.
Doerner, Johannes, Hubert Zirngibl, Maximilian Ackermann, et al.. (2023). A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors. Cell Death and Disease. 14(2). 104–104. 5 indexed citations
4.
5.
Zeiner, Pia S., Jenny Zinke, Daniel J. Kowalewski, et al.. (2018). CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival. Acta Neuropathologica Communications. 6(1). 18–18. 24 indexed citations
6.
Thiele, Jürgen & H. M. Kvasnicka. (2007). Myelofibrosis – What’s in a Name?. Pathobiology. 74(2). 89–96. 18 indexed citations
7.
Thiele, J., et al.. (2006). Trisomy 8 in Prefibrotic Early Stages of Chronic Idiopathic Myelofibrosis: A Fluorescence in situ Study of Bone Marrow Biopsies. Acta Haematologica. 115(1-2). 97–101. 1 indexed citations
8.
Thiele, J., H. M. Kvasnicka, Annette Schmitt‐Graeff, et al.. (2005). Bone marrow changes in chronic myelogenous leukaemia after long‐term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patients. Histopathology. 46(5). 540–550. 12 indexed citations
9.
Thiele, J. & H. M. Kvasnicka. (2004). Prefibrotic Chronic Idiopathic Myelofibrosis – A Diagnostic Enigma?. Acta Haematologica. 111(3). 155–159. 26 indexed citations
10.
Thiele, J., Claudia Wickenhauser, H. M. Kvasnicka, et al.. (2003). Mixed Chimerism of Erythro- and Megakaryopoiesis following Allogeneic Bone Marrow Transplantation. Acta Haematologica. 109(4). 176–183. 8 indexed citations
11.
Thiele, J., H. M. Kvasnicka, R. Zankovich, & Volker Diehl. (2002). Early-stage Idiopathic (Primary) Myelofibrosis—Current Issues of Diagnostic Features. Leukemia & lymphoma. 43(5). 1035–1041. 30 indexed citations
12.
Thiele, Jürgen, et al.. (2001). The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.. PubMed. 86(4). 368–74. 37 indexed citations
13.
Thiele, J., H. M. Kvasnicka, Annette Schmitt‐Graeff, et al.. (2001). Bone Marrow Histopathology Predicting Blast Crisis in Chronic Myeloid Leukemia. Acta Haematologica. 105(4). 244–246. 1 indexed citations
14.
Thiele, J., et al.. (2001). Polycythemia rubra vera versus Secondary Polycythemias. A Clinicopathological Evaluation of Distinctive Features in 199 Patients. Pathology - Research and Practice. 197(2). 77–84. 43 indexed citations
15.
Thiele, J. & H. M. Kvasnicka. (2000). Polyglobulie versus Polycythämia vera. Der Pathologe. 21(1). 24–30. 2 indexed citations
17.
Kvasnicka, H. M., et al.. (1999). Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis. Annals of Hematology. 78(2). 65–72. 14 indexed citations
19.
Kvasnicka, H. M. & J. Thiele. (1995). Dreidimensionale Rekonstruktion von Serienschnitten in der Lichtmikroskopie. Der Pathologe. 16(2). 128–138. 5 indexed citations
20.
Thiele, J., H. M. Kvasnicka, R.L. Nebel, et al.. (1993). Histological features of prognostic significance in CML — an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow. Annals of Hematology. 66(6). 291–302. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026